HOME >> BIOLOGY >> NEWS
Hydroxyurea therapy improves survival in most severely affected sickle cell patients

the treatment of sickle cell anemia. "Presently only a minority of eligible patients are taking hydroxyurea. Our study strongly suggests that adults with sickle cell anemia and clinically significant complications of their disease, like frequent painful episodes and the common pneumonia-like events, should take hydroxyurea under the supervision of a knowledgeable physician," Steinberg said.

"Most people who take this medication will feel better; we now know they will live longer," Steinberg added. Patients in the study will be followed for an additional 5 years, noted Bonds, who also added that hydroxyurea studies in children are planned.

Sickle cell anemia is an inherited disease that is most common among people whose ancestors come from Africa, the Middle East, the Mediterranean basin, and India. In the U.S., it affects primarily African Americans, about 72,000 of whom have the disease. One in 12 African Americans carries the sickle cell trait.

In patients with the disease, molecules of sickle hemoglobin stick to one another, forming long rods inside red blood cells and causing these cells to take on a sickle shape and become rigid. The sickled red cells are unable to squeeze through tiny blood vessels, depriving tissue of an adequate blood supply and causing painful episodes.


'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
1-Apr-2003


Page: 1 2 3

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2018)... , ... October 17, 2018 ... ... search firm for life sciences, diagnostics, and scientific healthcare companies, proudly announces ... 25, 2018 in South San Francisco. In conjunction with co-producer Biocom, the ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... biotherapeutics development, announces a new publication titled, “ Graphene-based Biosensor for On-Chip Detection ... paper describes Agile R100 as a “new portable digital device for biosensing… that ...
(Date:10/11/2018)... DURHAM, N.C. (PRWEB) , ... ... ... a nonprofit organization that identifies, counsels, and supports high-growth, high-impact life science ... investment professionals representing 8 national nonprofit disease foundations to discuss their investment ...
Breaking Biology News(10 mins):
(Date:10/18/2018)... ... 18, 2018 , ... With rapid technological advances in the fertility field, increasing ... for women facing a cancer diagnosis requiring chemotherapy or removal of an ovary, most ... Simply put, they do not want to get pregnant now but may want to ...
(Date:10/17/2018)... ... 2018 , ... PathSensors’ cutting-edge CANARY based assays for the ... and Plant Health Inspection Service for use in regulatory diagnostics. By going through ... they will be able to rapidly and accurately test and identify these damaging ...
(Date:10/16/2018)... (PRWEB) , ... October 15, 2018 , ... ... characterized tissues through the visualization of histopathology slides by eye wherein key features ... gold standard for diagnosis and research, it is highly limited in that it ...
(Date:10/11/2018)... BOSTON (PRWEB) , ... October 10, 2018 , ... ... for the biotech community, announces the appointment of Wendy Nelson, PhD, as its ... management, operational and R&D experience in the biotech industry. Most recently, Dr. ...
Breaking Biology Technology:
Cached News: